AUS
NZ
UK
CA
USA
IND
_10_04_2024_16_38_50_427275.jpg)
Highlights
Latrobe Magnesium initiates capital raising to support plant operations and strategic goals
Demonstration Plant expected to begin producing magnesium oxide within the coming months
Additional financing secured through institutional placement, share purchase plan, and asset sale
Latrobe Magnesium Ltd (ASX:LMG, OTC:LTRBF), an Australian-based company in the industrial and Energy Stocks, ASX 200 sector, is advancing efforts to recommence operations at its magnesium oxide Demonstration Plant. The company has outlined a structured funding approach to support the restart and ongoing operations, marking a significant phase in its strategic development plan.
Capital Raising and Financial Support
Latrobe Magnesium has completed a placement to institutional participants and launched a share purchase plan, both contributing to a multi-million-dollar funding initiative. This will enable the issuance of a large number of new shares at a discount to the previous trading price. The company’s board has also committed a substantial portion of their own capital to the placement, reinforcing internal support for the initiative.
In parallel, the company has gained approval to draw from its existing debt facility, with an updated agreement reducing the applicable interest rate. This facility will be used to assist in operational costs and project development, supported by a forecast rebate through the national tax system.
Asset Sale to Boost Liquidity
To further strengthen its financial position, Latrobe Magnesium plans to divest surplus land at its Tramway Road location. The proceeds from this transaction are expected to support the company’s broader development goals, including the demonstration of consistent magnesium oxide production and the continued build-out of the magnesium metal segment.
Operational Readiness and Strategic Goals
The company is preparing to bring its Demonstration Plant back online. Work is currently underway to secure required labour resources, replenish process materials, finalize remaining raw material stockpiles, and reinstate plant management. Additionally, an environmental review process remains ongoing, with completion anticipated prior to the resumption of operations.
The upcoming plant activity is aimed at establishing continuous production of magnesium oxide. This output will be made available to existing Australian customers. Data generated from operations will also contribute to regulatory planning and workforce training for subsequent phases.
Use of Funds and Financial Outlook
The capital raised will support several key areas, including plant commissioning, supply chain readiness, and compliance efforts. In addition to the placement and share plan, further funding will be unlocked from an existing research and development loan facility. A portion of this will be disbursed immediately, with the remainder available as operations continue.
As of the last reporting period, total obligations under this facility had grown, but the company expects repayment to be covered by its future rebate claim. The precise rebate amount will depend on operational spending through the financial year-end.
